Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
S. Wiscombe, J. Newton, C. Day, J. Gibson, S. West (Newcastle-upon-Tyne, United Kingdom). Increased risk of obstructive sleep apnoea in patients with non-alcoholic fatty liver disease. Eur Respir J 2012; 40: Suppl. 56, 3876

Member's Comments

No comment yet.

Related content which might interest you: The impact of severe obstructive sleep apnea and obesity on nonalcoholic fatty liver disease. Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities Year: 2017 Association between obstructive sleep apnea and the severity of non-alcoholic fatty liver disease. Source: International Congress 2019 – Impact of sleep-disordered breathing in other diseases Year: 2019 Association between obstructive sleep apnea and nonalcoholic fatty liver disease Source: International Congress 2019 – Impact of sleep-disordered breathing in other diseases Year: 2019 In sleep apnea patients nonalcoholic fatty liver disease (NAFLD) is associated with the severity of intermittent hypoxia and more severe endothelial dysfunction Source: Annual Congress 2012 - Sleep disorders in internal medicine Year: 2012 Free fatty acids levels and the metabolic syndrome in patients with obstructive sleep apnea Source: Annual Congress 2010 - Obesity: positive effects of bariatric surgery and exercise Year: 2010 Nonalcoholic fatty liver disease in chronic obstructive pulmonary disease Source: Eur Respir J, 49 (6) 1601923; 10.1183/13993003.01923-2016 Year: 2017 Relationship between OSA and non-alcoholic fatty liver disease Source: ERS Conference Year: 2015 Markers of liver dysfunction in patients with obstructive sleep apnea Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism Year: 2011 Increased liver stiffness in patients with severe sleep apnoea and metabolic comorbidities Source: Eur Respir J, 51 (6) 1800601; 10.1183/13993003.00601-2018 Year: 2018 Prevalence of thyroid disease in patients with obstructive sleep apnea Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity Year: 2011 Prevalence of co-morbidities and clinical features in patients with obstructive sleep apnea and chronic obstructive pulmonary disease. Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS) Year: 2018 Leukocytosis as a marker of chronic inflammation and early cardiovascular risk in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2007; 30: Suppl. 51, 593s Year: 2007 High prevalence of obstructive sleep apnea syndrome in nondialyzed severe chronic renal failure patients Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea Year: 2009 Prevalence of metabolic syndrome in patients with hypertension and obstructive sleep apnea Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea Year: 2009 Autoantibody against NBL1 in obstructive sleep apnea patients with cardiovascular disease Source: International Congress 2017 – New insights into the understanding of sleep and the consequences of sleep apnoea Year: 2017 Clinical phenotypes in patients with concomitant obstructive sleep apnea and chronic obstructive pulmonary disease Source: Annual Congress 2012 - Pharmacological and non-pharmacological management of COPD Year: 2012 Free fatty acids and the metabolic syndrome in patients with obstructive sleep apnoea Source: Eur Respir J 2011; 37: 1418-1423 Year: 2011 Unrecognised systemic hypertension in patients with obstructive sleep apnoea Source: Eur Respir J 2006; 28: Suppl. 50, 643s Year: 2006 Prevalence of obstructive airway disease in patients with obstructive sleep apnea Source: Annual Congress 2012 - Physiology, heart failure and respiration in relation to OSA Year: 2012 Incidence of cardiovascular complications in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders Year: 2007